2.39 USD
↘ 0.29 (10.82%)AT CLOSE (11:59 AM EDT)
Nautilus Biotechnolgy, Inc. Common Stock
NAUTNASDAQ • USD
2.39
↗ 0.00 (0.17%)
POST MARKET (AS OF 07:39 PM EDT)
Post Market
AS OF 07:39 PM EDT
2.39
↗ 0.00 (0.17%)
Market: CLOSED
Open?$2.65
High?$2.67
Low?$2.37
Prev. Close?$2.68
Volume?491.5K
Avg. Volume?398.7K
VWAP?$2.47
Rel. Volume?1.23x
Bid / Ask
Bid?$2.36 × 100
Ask?$2.59 × 10.0K
Spread?$0.23
Midpoint?$2.47
Valuation & Ratios
Market Cap?303.7M
Shares Out?127.1M
Float?34.7M
Float %?27.4%
P/E Ratio?N/A
P/B Ratio?2.10
EPS?-$0.45
Dividend?0.00%
Ex-Dividend?N/A
Nautilus Biotechnolgy, Inc. Common Stock (NAUT) trades at $2.39 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, NAUT appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Themes
Employees
130
Market Cap
340.6M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
Listed
2021-06-10
Address
2701 EASTLAKE AVE EAST
SEATTLE, WA 98102
Phone: 206-333-2001
SEATTLE, WA 98102
Phone: 206-333-2001
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?57
Momentum?50
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?2.59Grey
Confidence?48%Low
Short InterestLow
Short % of Float?2.38%Low
Short Interest?825.0K
Days to Cover?2.1
Free Float34.7M
Avg Daily Volume390.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?11.85Strong
Quick Ratio?11.85Strong
Cash Ratio?1.75Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.10CHEAP▾
Peers100
S&P72
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-39.5%WEAK▾
S&P3
ROA?-32.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51427000
Enterprise Value?$289.1M
Fundamentals ratios updated end of day